Votrient (pazopanib tablets) — Cigna
Gastrointestinal Stromal Tumor (GIST)
Preferred products
- imatinib
- sunitinib
- Stivarga (regorafenib tablets)
- Qinlock (ripretinib tablets)
Initial criteria
- Patient age ≥ 18 years
- Patient has succinate dehydrogenase (SDH)-deficient GIST OR has tried ALL of the following: imatinib AND sunitinib AND Stivarga (regorafenib) AND Qinlock (ripretinib)
Approval duration
1 year